LEADER 00970nam0-2200325---450- 001 990009427210403321 005 20110920123805.0 035 $a000942721 035 $aFED01000942721 035 $a(Aleph)000942721FED01 035 $a000942721 100 $a20110920d1963----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aa-------000yy 200 1 $aAttualita' degli orti botanici$fValerio Giacomini, Aldo Merola 210 $aRoma$cIstituto di tecnica e propaganda agraria$d1963 215 $a22 p.$cill.$d31 cm 300 $aEstr. da: Agricoltura, n. 4, aprile 1963 610 0 $aOrti botanici 676 $a580.744$v20$zita 700 1$aGiacomini,$bValerio$f<1914-1981>$032302 701 1$aMerola,$bAldo$0512657 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009427210403321 952 $a60 DONO CATALANO 80$b13329$fFAGBC 959 $aFAGBC 996 $aAttualita' degli orti botanici$9760124 997 $aUNINA LEADER 00982nam--2200361---450- 001 990001930410203316 005 20050715115240.0 035 $a000193041 035 $aUSA01000193041 035 $a(ALEPH)000193041USA01 035 $a000193041 100 $a20040813d1975----km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $aa|||||||001yy 200 1 $aEliot$fStephen Spender 210 $aFontana$cCollins$d1975 215 $a251 p.$cill.$d20 cm 225 2 $aModern Masters$v3467 410 0$12001$aModern Masters$v3467 454 1$12001 461 1$1001-------$12001 600 1 $aEliot,$bR. S. 700 1$aSPENDER,$bStephen$0329613 801 0$aIT$bsalbc$gISBD 912 $a990001930410203316 951 $aVII.3.B. 806(II i A coll 24/3467)$b81152 L.M.$cII i A coll 959 $aBK 969 $aUMA 979 $aSIAV5$b10$c20040813$lUSA01$h1323 979 $aCOPAT3$b90$c20050715$lUSA01$h1152 996 $aEliot$91045000 997 $aUNISA LEADER 05790nam 2201885z- 450 001 9910639990003321 005 20231214133618.0 010 $a3-0365-5927-2 035 $a(CKB)5470000001633454 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/95801 035 $a(EXLCZ)995470000001633454 100 $a20202301d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aStrategies to Improve Antineoplastic Activity of Drugs in Cancer Progression 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (416 p.) 311 $a3-0365-5928-0 330 $aThe aim of this Special Issue is to collect reports regarding all the recent strategies, directed at the improvement of antineoplastic activity of drugs in cancer progression, engaging all the expertise needed for the development of new anticancer drugs: medicinal chemistry, pharmacology, molecular biology, and computational and drug delivery studies. 606 $aResearch & information: general$2bicssc 606 $aBiology, life sciences$2bicssc 610 $aEGR-1 610 $aflavonoid 610 $a(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile 610 $aMDA-MB-231 610 $aMMP9 610 $aTNF? 610 $apancreatic ductal adenocarcinoma 610 $acyclodextrin inclusion complex 610 $aphase solubility studies 610 $apreformulation studies 610 $abiphenylnicotinamide derivatives 610 $adual inhibitor 610 $aEGFR 610 $aVEGFR2 610 $aligand-based pharmacophore 610 $amolecular docking 610 $amolecular dynamics 610 $aleukemias 610 $adoxorubicin 610 $ainflammation 610 $adrug delivery 610 $atumor targeting 610 $aelastin-like polypeptide 610 $acell penetrating peptide 610 $amatrix metalloproteinase 610 $adoxorubicin resistance 610 $aphotosensitizer delivery system 610 $aPAMAM dendrimer 610 $aphotodynamic therapy 610 $acytotoxicity 610 $aphototoxicity 610 $acolorectal adenocarcinoma 610 $adicarboximides 610 $achemical synthesis 610 $aapoptosis 610 $akinases 610 $aanticancer 610 $agene profiling 610 $aSAR 610 $abiomarkers 610 $acolorectal cancer 610 $aearly detection examination 610 $aliquid biopsy 610 $apersonalized medicine 610 $atumor treatment 610 $aexosomes 610 $actDNA 610 $aCTC 610 $acytotoxic activity 610 $apyrazole derivatives 610 $aMTT assay 610 $aADMET analysis 610 $asingle-crystal diffraction 610 $aFTIR spectroscopy 610 $aNMR spectroscopy thermogravimetric analysis 610 $aacute myelogenous leukemia 610 $aplatelets 610 $amicroparticles 610 $a?? T cells 610 $aimmunotherapy 610 $atumor resistance 610 $acombination therapy 610 $atumor microenvironment 610 $aimmune checkpoint inhibitor 610 $aneuroblastoma 610 $amolecular iodine 610 $acyclophosphamide 610 $axenografts 610 $ametronomic therapy 610 $atamoxifen 610 $aCYP2D6 610 $aMCF-7 610 $aIshikawa cells 610 $aSERM 610 $aTNBC 610 $auterotrophic 610 $a?-mangostin 610 $apoly(amidoamine) dendrimer 610 $atargeted drug delivery 610 $abiotin targeting 610 $aglioblastoma multiforme 610 $asquamous cell carcinoma 610 $aantiparasitic therapy 610 $adiclofenac 610 $aindomethacin 610 $aoleanolic acid derivative conjugates 610 $aNF-?B 610 $aNrf2 610 $aMAPKs 610 $aPSN-1 cells 610 $areactive oxygen species 610 $aglioblastoma 610 $abrain tumor 610 $aextracellular vesicles 610 $apancreatic cancer 610 $apaclitaxel 610 $aclathrin 610 $aendocytosis 610 $asulforaphane 610 $anicotine 610 $ametalloproteinase-9 610 $agastric cancer 610 $acell invasion 610 $aArylquin 1 610 $acolon cancer 610 $atumor progression 610 $aazelastine 610 $aoxidative stress 610 $aautophagy 610 $amitotic catastrophe 610 $achronic myeloid leukemia 610 $aimatinib 610 $atyrosine kinase 610 $aketoconazole 610 $aP-glycoprotein 610 $adrug efflux transporter 610 $anon-small-cell lung cancer 610 $acisplatin resistance 610 $aaldehyde dehydrogenase 610 $aisothiocyanates 610 $adisulfiram 610 $aepithelial to mesenchymal transition 610 $aaminopeptidase N 610 $aacetamidophenones 610 $aSchiff bases 610 $asemicarbazones 610 $athiosemicarbazones 610 $ainhibition of proliferation 615 7$aResearch & information: general 615 7$aBiology, life sciences 700 $aStefanachi$b Angela$4edt$01323363 702 $aStefanachi$b Angela$4oth 906 $aBOOK 912 $a9910639990003321 996 $aStrategies to Improve Antineoplastic Activity of Drugs in Cancer Progression$93035463 997 $aUNINA